arginine vasopressin has been researched along with Hypertension, Portal in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (9.52) | 18.7374 |
| 1990's | 6 (28.57) | 18.2507 |
| 2000's | 8 (38.10) | 29.6817 |
| 2010's | 5 (23.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chuang, CL; Huang, HC; Huo, TI; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Austin, A; Freeman, J; Lo, R | 1 |
| Heinemann, A; Lippe, IT; Schuligoi, R; Stauber, RE | 1 |
| Chang, CC; Chen, YC; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Teng, TH; Wang, SS | 1 |
| Chang, CC; Chen, YC; Huang, HC; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Huang, HC | 1 |
| Alonso, G; Azoulay, D; Castaing, D; Doignon, I; Duclos-Vallée, JC; Garcin, I; Gigou, M; Gillon, MC; Humbert, L; Julien, B; Monnet, F; Nicou, A; Rainteau, D; Samuel, D; Serrière-Lanneau, V; Tordjmann, T | 1 |
| Chang, CC; Chuang, CL; Huang, HC; Huo, TI; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Wang, SS | 1 |
| IMANAGA, H; KONDO, T; MORI, I | 1 |
| Chan, CC; Chang, FY; Hou, MC; Huang, HC; Lai, IN; Lee, FY; Lee, SD; Lin, HC; Tai, CC; Wang, SS | 1 |
| Henriksen, JH; Møller, S | 1 |
| Aragno, M; Danni, O; Mastrocola, R; Mengozzi, G; Parola, M; Restivo, F; Rizzetto, M; Rosina, F; Sansoè, G; Smedile, A | 1 |
| Peters, J; Treschan, TA | 1 |
| Chang, CC; Chang, FY; Chen, YC; Hou, MC; Huang, HC; Lee, FY; Lee, SD; Lin, HC; Wang, SS | 1 |
| Howard, MM; Leevy, CM; Rocko, JM; Rush, BF; Swan, KG; Timmes, JJ | 1 |
| Goff, JS | 1 |
| Benoit, JN; Granger, DN; Joh, T | 1 |
| Fickert, P; Heinemann, A; Holzer, P; Stauber, RE; Wachter, CH | 1 |
| Burns, RC; Sitzmann, JV; Wu, Y | 1 |
| Groszmann, RJ; Sieber, CC | 1 |
| Benoit, JN; Granger, DN; Joh, T; Korthuis, RJ; Mesh, CL | 1 |
4 review(s) available for arginine vasopressin and Hypertension, Portal
| Article | Year |
|---|---|
Vasopressin in liver disease--should we turn on or off?
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Hemodynamics; Humans; Hypertension, Portal; Hyponatremia; Kidney Failure, Chronic; Liver Diseases; Receptors, Vasopressin | 2008 |
Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
Topics: Arginine Vasopressin; Autonomic Nervous System Diseases; Blood Circulation; Blood Pressure; Cardiac Output; Endothelins; Hepatorenal Syndrome; Humans; Hypertension, Portal; Hypotension; Nitric Oxide; Renin-Angiotensin System; Vasoconstriction; Vasodilation | 2004 |
The vasopressin system: physiology and clinical strategies.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Cardiopulmonary Resuscitation; Hemostasis; Humans; Hypertension; Hypertension, Portal; Neuroendocrine Tumors; Shock, Septic; Vasopressins; Water-Electrolyte Balance | 2006 |
Gastroesophageal varices: pathogenesis and therapy of acute bleeding.
Topics: Acute Disease; Arginine Vasopressin; Combined Modality Therapy; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Hemostasis, Endoscopic; Humans; Hypertension, Portal; Injections; Intubation, Gastrointestinal; Ligation; Polymers; Randomized Controlled Trials as Topic; Risk Factors; Sclerotherapy; Somatostatin; Surgical Procedures, Operative | 1993 |
17 other study(ies) available for arginine vasopressin and Hypertension, Portal
| Article | Year |
|---|---|
Diabetes diminishes the portal-systemic collateral vascular response to vasopressin via vasopressin receptor and Gα proteins regulations in cirrhotic rats.
Topics: Animals; Arginine Vasopressin; Blood Glucose; Collateral Circulation; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; GTP-Binding Protein alpha Subunits; Hemodynamics; Hypertension, Portal; Liver Cirrhosis; Male; Rats; Receptors, Vasopressin | 2013 |
Restriction of drinking water abrogates splanchnic vasodilation and portal hypertension in portal vein-ligated rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Disease Models, Animal; Hyperemia; Hypertension, Portal; Ligation; Liver Diseases; Male; Mesenteric Artery, Superior; Portal Vein; Rats; Rats, Sprague-Dawley; Splanchnic Circulation; Vasoconstrictor Agents; Vasodilation; Vasopressins; Water Deprivation | 2009 |
Evolution of portal-systemic collateral vasopressin response in endotoxemic portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Endothelin-1; Endotoxemia; Hemodynamics; Hypertension, Portal; Lipopolysaccharides; Male; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Vasoconstrictor Agents | 2009 |
Simvastatin effects on portal-systemic collaterals of portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Collateral Circulation; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprost; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Hemodynamics; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension, Portal; Male; Membrane Proteins; Nitrates; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Portal Pressure; Portal System; Rats; Rats, Sprague-Dawley; RNA, Messenger; Simvastatin; Thromboxane B2; Thromboxane-A Synthase; Time Factors; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Investigating the vascular influences of sepsis in portal hypertension: better late than never?
Topics: Animals; Arginine Vasopressin; Hypertension, Portal; Mesenteric Artery, Superior; Nitric Oxide; Rats; Sepsis; Vasoconstriction | 2010 |
Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis.
Topics: Adult; Animals; Arginine Vasopressin; Bile Acids and Salts; Blood Pressure; Cholestasis; Female; Hepatectomy; Humans; Hypertension, Portal; Liver Regeneration; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Models, Animal; Neurosecretory Systems; Portal System; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Supraoptic Nucleus | 2011 |
Propranolol modulates the collateral vascular responsiveness to vasopressin via a G(α)-mediated pathway in portal hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Arginine Vasopressin; Collateral Circulation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Gene Expression Regulation; GTP-Binding Protein alpha Subunits; Hemodynamics; Hypertension, Portal; Liver Circulation; Male; Propranolol; Rats; Rats, Sprague-Dawley; Signal Transduction; Suramin; Vasoconstrictor Agents | 2011 |
Inactivation of antidiuretic substance by human liver.
Topics: Arginine Vasopressin; Humans; Hypertension; Hypertension, Portal; Liver; Vasopressins | 1957 |
Chronic inhibition of nitric oxide increases the collateral vascular responsiveness to vasopressin in portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Collateral Circulation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hypertension, Portal; Ligation; Liver Circulation; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Portal Vein; Rats; Rats, Sprague-Dawley | 2004 |
Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Blood Pressure; Carbon Tetrachloride; Cyclic GMP; Cyclohexanecarboxylic Acids; Cytokines; Endothelin-1; Humans; Hypertension, Portal; Liver; Liver Cirrhosis, Experimental; Male; Neprilysin; Portal Vein; Protease Inhibitors; Rats; Rats, Wistar; Vascular Resistance | 2005 |
Chronic cyclooxygenase blockade enhances the vasopressin responsiveness in collaterals of portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Collateral Circulation; Cyclooxygenase Inhibitors; Disease Models, Animal; Hypertension, Portal; Indomethacin; Portal System; Random Allocation; Rats; Vascular Resistance | 2006 |
Operative vasopressin and mesocaval shunting for portal hypertension.
Topics: Aged; Arginine Vasopressin; Blood Vessel Prosthesis; Esophageal and Gastric Varices; Female; Hepatic Veins; Humans; Hypertension, Portal; Intraoperative Period; Male; Mesenteric Veins; Methods; Middle Aged; Portal Vein; Vena Cava, Inferior; Venous Pressure | 1980 |
Endogenous vasoconstrictor tone in intestine of normal and portal hypertensive rats.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Hypertension, Portal; Intestines; Male; Microcirculation; Norepinephrine; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vasoconstriction; Vasodilation | 1993 |
Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Endothelin-1; Enzyme Inhibitors; Hemodynamics; Hypertension, Portal; In Vitro Techniques; Male; Mesenteric Arteries; Methoxamine; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Vasodilator Agents | 1997 |
Diminished angiotensin-II and intact vasopressin response to hemorrhage in portal hypertension.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Hemodynamics; Hemorrhage; Hypertension, Portal; Male; Rabbits; Renin-Angiotensin System | 1998 |
Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Hypertension, Portal; Male; Mesenteric Arteries; Nitric Oxide; Norepinephrine; Potassium Chloride; Rats; Rats, Inbred Strains; Vasoconstrictor Agents | 1992 |
Intestinal vascular sensitivity to vasopressin in portal hypertensive rats.
Topics: Animals; Arginine Vasopressin; Chronic Disease; Glucagon; Hypertension, Portal; Intestine, Small; Male; Nitroprusside; Rats; Rats, Inbred Strains; Vascular Resistance; Vasoconstriction | 1991 |